SecBot SecBot
8-K ·Filed Nov 4, 2026

IVF

INVO Fertility, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 10h ago SEC0001493152-26-049991
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor for potential Nasdaq compliance improvement or future financing needs; reverse splits often precede capital raises but no offering is announced here.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$2.03
T+0 close · Nov 4, 2026 · via day close
Latest settled
+32.27%
T+5 · $2.69 · next T+20 in 17d
Vs SPY
+28.98%
α at T+5
Latest observation
+40.65%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $2.03entry
  2. T+1 · 11d ago +5.42%α +5.11% · $2.14
  3. T+5 · 5d ago +32.27%α +28.98% · $2.69
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

INVO Fertility filed an 8-K to report a 1-for-4 reverse stock split effective October 30, 2026, reducing outstanding shares to approximately 1,192,841 and authorized shares to 62,500,000. The split is a routine capital structure adjustment with no direct financial impact on operations or fundamentals.

Key Facts

  • 1-for-4 reverse stock split effective October 30, 2026
  • Outstanding shares reduced to approximately 1,192,841 post-split
  • Authorized shares reduced to 62,500,000 post-split
  • No fractional shares issued; rounding up for record holders, cash for street name holders
  • CUSIP changed to 44984F872; trading symbol remains IVF
  • Market cap is $2M with normal daily move of 5.4%

Financial Impact

No change in total equity value; share count reduced by 75% with proportionate price adjustment

shares outstandingauthorized shares

Risk Factors

  • Reverse splits can signal financial distress and may reduce liquidity
  • No operational improvement or financial data provided in this filing

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
80% bullish (5 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-049991
Exhibit: ex99-1.htm0001493152-26-049991
Document: 0001493152-26-049991-index-headers.html0001493152-26-049991
Document: 0001493152-26-049991-index.html0001493152-26-049991
Document: 0001493152-26-049991.txt0001493152-26-049991

Track record

18 reports on IVF

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +59.15% at T+60 after the Aug 17, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $2.27 Now $2.40 +5.65% settles Feb 16
  2. Nov 16, 2026today Press Release Neutral 4/10 Entry $2.70 Now $2.40 −11.11% settles Feb 12
  3. Nov 4, 202612d ago 8-K Neutral 2/10 Viewing Entry $2.03 Now $2.40 +18.23% settles Feb 3
  4. Oct 27, 202620d ago Press Release Neutral 3/10 Entry $0.5561 Now $2.40 +331.58% settles Jan 26
  5. Oct 9, 20265w ago SC 13G/A Bearish 4/10 Entry $0.7275 Now $2.40 −229.90% settles Jan 6
  6. Aug 28, 202611w ago 8-K Bearish 6/10 Entry $1.00 Now $2.40 −140.00% settles Nov 23
  7. Aug 17, 202613w ago 8-K Neutral 4/10 No price data
  8. Aug 17, 202613w ago Press Release Bearish 6/10 Entry $1.53 to $0.6250 Now $2.40 −56.86% ▲ +59.15% +56.21% vs SPY
  9. Aug 5, 202614w ago EFFECT Bearish 5/10 Entry $1.08 to $0.5361 Now $2.40 −123.26% ▲ +50.13% +50.07% vs SPY
  10. Jun 25, 202620w ago 8-K Neutral 4/10 Entry $2.45 to $0.9580 Now $2.40 −2.04% ▼ −60.90% −67.00% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens in 5h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026